Cargando…

Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis

Combinations of three or more drugs are used to treat many diseases, including tuberculosis. Thus, it is important to understand how synergistic or antagonistic drug interactions affect the efficacy of combination therapies. However, our understanding of high-order drug interactions is limited becau...

Descripción completa

Detalles Bibliográficos
Autores principales: Cokol, Murat, Kuru, Nurdan, Bicak, Ece, Larkins-Ford, Jonah, Aldridge, Bree B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636204/
https://www.ncbi.nlm.nih.gov/pubmed/29026882
http://dx.doi.org/10.1126/sciadv.1701881
_version_ 1783270404866965504
author Cokol, Murat
Kuru, Nurdan
Bicak, Ece
Larkins-Ford, Jonah
Aldridge, Bree B.
author_facet Cokol, Murat
Kuru, Nurdan
Bicak, Ece
Larkins-Ford, Jonah
Aldridge, Bree B.
author_sort Cokol, Murat
collection PubMed
description Combinations of three or more drugs are used to treat many diseases, including tuberculosis. Thus, it is important to understand how synergistic or antagonistic drug interactions affect the efficacy of combination therapies. However, our understanding of high-order drug interactions is limited because of the lack of both efficient measurement methods and theoretical framework for analysis and interpretation. We developed an efficient experimental sampling and scoring method [diagonal measurement of n-way drug interactions (DiaMOND)] to measure drug interactions for combinations of any number of drugs. DiaMOND provides an efficient alternative to checkerboard assays, which are commonly used to measure drug interactions. We established a geometric framework to factorize high-order drug interactions into lower-order components, thereby establishing a road map of how to use lower-order measurements to predict high-order interactions. Our framework is a generalized Loewe additivity model for high-order drug interactions. Using DiaMOND, we identified and analyzed synergistic and antagonistic antibiotic combinations against Mycobacterium tuberculosis. Efficient measurement and factorization of high-order drug interactions by DiaMOND are broadly applicable to other cell types and disease models.
format Online
Article
Text
id pubmed-5636204
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-56362042017-10-12 Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis Cokol, Murat Kuru, Nurdan Bicak, Ece Larkins-Ford, Jonah Aldridge, Bree B. Sci Adv Research Articles Combinations of three or more drugs are used to treat many diseases, including tuberculosis. Thus, it is important to understand how synergistic or antagonistic drug interactions affect the efficacy of combination therapies. However, our understanding of high-order drug interactions is limited because of the lack of both efficient measurement methods and theoretical framework for analysis and interpretation. We developed an efficient experimental sampling and scoring method [diagonal measurement of n-way drug interactions (DiaMOND)] to measure drug interactions for combinations of any number of drugs. DiaMOND provides an efficient alternative to checkerboard assays, which are commonly used to measure drug interactions. We established a geometric framework to factorize high-order drug interactions into lower-order components, thereby establishing a road map of how to use lower-order measurements to predict high-order interactions. Our framework is a generalized Loewe additivity model for high-order drug interactions. Using DiaMOND, we identified and analyzed synergistic and antagonistic antibiotic combinations against Mycobacterium tuberculosis. Efficient measurement and factorization of high-order drug interactions by DiaMOND are broadly applicable to other cell types and disease models. American Association for the Advancement of Science 2017-10-11 /pmc/articles/PMC5636204/ /pubmed/29026882 http://dx.doi.org/10.1126/sciadv.1701881 Text en Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (http://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
spellingShingle Research Articles
Cokol, Murat
Kuru, Nurdan
Bicak, Ece
Larkins-Ford, Jonah
Aldridge, Bree B.
Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis
title Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis
title_full Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis
title_fullStr Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis
title_full_unstemmed Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis
title_short Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis
title_sort efficient measurement and factorization of high-order drug interactions in mycobacterium tuberculosis
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636204/
https://www.ncbi.nlm.nih.gov/pubmed/29026882
http://dx.doi.org/10.1126/sciadv.1701881
work_keys_str_mv AT cokolmurat efficientmeasurementandfactorizationofhighorderdruginteractionsinmycobacteriumtuberculosis
AT kurunurdan efficientmeasurementandfactorizationofhighorderdruginteractionsinmycobacteriumtuberculosis
AT bicakece efficientmeasurementandfactorizationofhighorderdruginteractionsinmycobacteriumtuberculosis
AT larkinsfordjonah efficientmeasurementandfactorizationofhighorderdruginteractionsinmycobacteriumtuberculosis
AT aldridgebreeb efficientmeasurementandfactorizationofhighorderdruginteractionsinmycobacteriumtuberculosis